- ASSISTANT PROFESSOR Neurology
MD, Yale University School of Medicine
Internship, Internal Medicine
St. Vincent's Hosp. Med. Ctr. of NY
Mount Sinai Hospital
Fellowship, Multiple Sclerosis
Mount Sinai Hospital
Stephen Krieger, MD, joined The Corinne Goldsmith Dickinson Center for MS as a fellow in multiple sclerosis after completing his Neurology residency training at Mount Sinai. He was the recipient of a 2006 American Academy of Neurology Scholarship and received a Sylvia Lawry Fellowship in clinical research from the National Multiple Sclerosis Society. He graduated summa cum laude from Columbia College, and received his MD degree from Yale University. He completed his medical internship at St. Vincent’s Hospital, Manhattan, and is board-certified in Neurology by the ABPN.
Dr. Krieger has a clinical practice at the CGDC for MS, and is participating in several MS clinical trials. In addition to his clinical work, he has an academic appointment as Assistant Professor of Neurology at the Mount Sinai School of Medicine, where he is Director of the Neurology Residency Training program. Dr. Krieger has received several teaching and mentorship awards and was inducted as a Fellow into the Institute for Medical Education in 2011. He is an active member of the American Academy of Neurology (AAN), who awarded him an A.B. Baker teaching recognition award in 2010.
He has presented work in Multiple Sclerosis at AAN, CMSC, ACTRIMS and ECTRIMS, and has written review articles on and lectures nationally about MS with an emphasis on emerging therapies.
Krieger S. Multiple sclerosis therapeutic pipeline: opportunities and challenges. The Mount Sinai journal of medicine, New York; 78(2).
Miller AE, Cohen BA, Krieger SC, Markowitz CE, Mattson DH, Tselentis HN. Constructing an adaptive care model for the management of disease-related symptoms throughout the course of multiple sclerosis--performance improvement CME. Multiple sclerosis (Houndmills, Basingstoke, England) 2013 Aug;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Krieger during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Acorda Therapeutics Inc.; Biogen Idec; Genzyme Corporation; Questcor Pharmaceuticals, Inc.
Scientific Advisory Board:
- Acorda Therapeutics Inc.; Bayer HealthCare Pharmaceuticals / Onyx Pharmaceuticals Partnership; Genzyme Corporation; Questcor Pharmaceuticals, Inc.; Teva Pharmaceutical Industries Ltd.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.
- Genzyme Corporation; Teva Pharmaceutical Industries Ltd.
Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.
- Gerson Lehrman Group; Teva Pharmaceutical Industries Ltd.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Faculty Practice Associates
5 East 98th Street
New York, NY 10029
5 East 98th Street, 1st Floor
New York, NY 10029
- Monday 9:00am - 5:00pm
- Tuesday 9:00am - 5:00pm
- Wednesday 9:00am - 5:00pm
- Thursday 9:00am - 5:00pm
- Friday 9:00am - 5:00pm
- Call Office to Inquire